NCT06940622View on ClinicalTrials.gov

A Trial of D-mannose for the Prophylaxis of Recurrent Urinary Tract Infections

NARecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

September 30, 2029

Study Completion Date

September 30, 2030

Conditions
Recurrent UTIsRecurrent Urinary Tract InfectionsRecurrent Urinary Tract Infections in WomenRecurrent Urinary Tract InfectionCystitis RecurrentCystitis ChronicUTIUTI - Urinary Tract InfectionUTI - Lower Urinary Tract Infection
Interventions
DIETARY_SUPPLEMENT

D-Mannose

D-mannose (2g, i.e., 4 x 500mg capsules) daily for 12 months.

DIETARY_SUPPLEMENT

Placebo

Placebo daily for 12 months.

Trial Locations (1)

75390

RECRUITING

University of Texas Southwestern Medical Center, Dallas

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER

NCT06940622 - A Trial of D-mannose for the Prophylaxis of Recurrent Urinary Tract Infections | Biotech Hunter | Biotech Hunter